When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
MP3•Episode home
Manage episode 513582758 series 3613984
Content provided by Audioboom and Stanford Medicine Health Compass. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Stanford Medicine Health Compass or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Laura Dassama, PhD, assistant professor of microbiology and immunology and of chemistry, is developing new a new type of therapy for patients who, like her, live with sickle cell disease, which is caused by a mutation in the gene that codes for hemoglobin, the protein responsible for the ability of red blood cells to carry oxygen. Dassama speaks to her experience with the illness and describes how her lab work takes inspiration from a form of hemoglobin active during fetal development, creating a new path of inquiry that she hopes will yield a new treatment for the condition.
Read more in Stanford Medicine magazine: https://stanmed.stanford.edu/innovations-help-chronically-ill-thrive/#sicklecell
Read more in Stanford Medicine magazine: https://stanmed.stanford.edu/innovations-help-chronically-ill-thrive/#sicklecell
12 episodes